Brief: Abcellera Biologics Says Under Agreement, Regeneron Has Right To Develop And Commercialize Therapeutic Antibodies Resulting From Collaboration
Sept 20 (Reuters) - Abcellera Biologics Inc ABCL.O :
* ABCELLERA EXPANDS MULTI-TARGET ANTIBODY DISCOVERY
COLLABORATION
WITH REGENERON
* ABCELLERA BIOLOGICS INC: UNDER AGREEMENT, REGENERON HAS
RIGHT
TO DEVELOP AND COMMERCIALIZE THERAPEUTIC ANTIBODIES RESULTING
FROM COLLABORATION
* ABCELLERA BIOLOGICS: UNDER DEAL, CO GETS RESEARCH
PAYMENTS,
ELIGIBLE TO GET DOWNSTREAM CLINICAL, REGULATORY MILESTONE
PAYMENTS, ROYALTIES ON NET SALES
Source text for Eikon: ID:nBw5g4BqQa
Further company coverage: ABCL.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on AbCellera Biologics
See all newsAbCellera Biologics Inc. reports results for the quarter ended September 30 - Earnings Summary
Canada's AbCellera Q3 revenue beats analyst estimates
Factbox: Pharma sector doubles down on AI to slash costs, timelines
U.S. STOCKS ON THE MOVE-Tapestry, Cisco, Sandisk
U.S. STOCKS ON THE MOVE-EnerSys, Netflix, Salesforce